Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00658294 |
Recruitment Status :
Completed
First Posted : April 14, 2008
Last Update Posted : October 17, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles
- Trial with medicinal product
Condition or disease | Intervention/treatment |
---|---|
Alveolar Echinococcosis | Other: Stop treatment |
Study Type : | Observational |
Actual Enrollment : | 34 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology |
Actual Study Start Date : | January 2008 |
Actual Primary Completion Date : | December 31, 2012 |
Actual Study Completion Date : | December 31, 2012 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion criteria:
- Patients with inoperable alveolar echinococcosis
- With negative PET-CT
- EmII/3-10 serology under long-term chemotherapy with benzimidazoles
Exclusion criteria:
- Positive PET-CT
- Positive EmII-3-10 Serology
- No compliance
- Reduced life expectancy
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00658294
Switzerland | |
University Hospital Zurich | |
Zurich, Switzerland |
Principal Investigator: | Beat Müllhaupt 01 Studienregister MasterAdmins | UniversitaetsSpital Zuerich |
Responsible Party: | University of Zurich |
ClinicalTrials.gov Identifier: | NCT00658294 |
Other Study ID Numbers: |
EK-1351 |
First Posted: | April 14, 2008 Key Record Dates |
Last Update Posted: | October 17, 2017 |
Last Verified: | October 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Echinococcosis Cestode Infections Helminthiasis Parasitic Diseases |